We are conveniently located in the San Francisco Bay Area. For any inquiries, please give us a call, email, or submit the form on this page and we will get back to you as soon as possible.
Engimata is an early stage biopharma company located in the San Francisco Bay Area. Engimata has developed a COVID-19 vaccine, using its platform nano lipid particle technology with recombinant viral surface proteins to mimic those found on the SARS-CoV-2 coronavirus particle.
